CONGRESS MATERIALS

Medical Information
Hong Kong
 
This website is intended only for healthcare professionals in the Hong Kong Special Administrative Region (HKSAR). This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.
 

Please choose the category that best describes you.

I am a Healthcare Professional in the HKSARYes, I am a healthcare professional
SelectI am a Healthcare Professional in the HKSARYes, I am a healthcare professional
I am NOT a Healthcare ProfessionalNo, go back to the patient portal
SelectI am NOT a Healthcare ProfessionalNo, go back to the patient portal

I am a healthcare professional in another country

The information on this page pertains to selected congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas. Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the local Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the local approved Prescribing Information. Where the product is not marketed in Hong Kong, all information in this document is off-label.
Poster
Lindsay A. George, Spencer K. Sullivan, John E.J. Rasko, Adam Giermasz, Benjamin J. Samelson-Jones, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Denis Rybin, Amanda O'Brien, Ian Winburn, John E. Murphy, Priya Patel, Amit Chhabra, Jeremy Rupon July 17, 2021 ISTH 2021 Hemophilia

Evaluation of Liver Health After Fidanacogene Elaparvovec Gene Therapy: Data from Study Participants With up to 5 Years of Follow-up

View Presentation
Poster
L.E. Markson, P.F. Fogarty, L. Ban, Y. Chen, R.Zaha, L. Young July 17, 2021 ISTH 2021 Hemophilia

Health Care Resource Use Among Adult Persons With Hemophilia A and Concurrent Joint Disease in the United States

View Presentation
Poster
L.E. Markson, L. Young, L. Ban, Y. Chen, R.Zaha, P.F. Fogarty July 17, 2021 ISTH 2021 Hemophilia

Health Care Resource Use Among Adult Persons With Hemophilia B and Concurrent Joint Disease in the United States

View Presentation
Oral Presentation
J. Mahlangu, J. L. Lamas, J. C. Morales, D. R. Malan, J. G. Teeter, R. J. Charnigo, M. Privette, E. Hwang, S. Arkin July 21, 2021 ISTH 2021 Hemophilia

Long-Term Safety and Efficacy of the Anti-TFPI Monoclonal Antibody Marstacimab in Patients With Severe Haemophilia A or B: Results From a Phase 2 Long-term Treatment Study

View Presentation
Poster
Benjamin J. Samelson-Jones, Spencer K. Sullivan, John E. J. Rasko, Adam Giermasz, Lindsey A. George, Jonathan M. Ducore, Jerome M. Teitel, Catherine E. McGuinn, Amanda O'Brien; Ian Winburn, Lynne M. Smith, Amit Chhabra, Jeremy Rupon December 14, 2021 ASH 2021 Hemophilia

Follow-up of More Than 5 Years in a Cohort of Participants With Hemophilia B Treated With Fidanacogene Elaparvovec Adeno-Associated Virus Gene Therapy

View Presentation
Oral Presentation
Nathan Visweshwar, Thomas J. Harrington, Andrew D. Leavitt, Barbara A. Konkle, Adam Giermasz, Kimo C. Stine, Jeremy Rupon, Gregory Di Russo, Li-Jung Tseng, Maria de los Angeles Resa, Florence Ganne, Delphine Agathon, Frank Plonski, Didier Rouy, Bettina M. Cockroft, Annie Fang, Steven Arkin December 14, 2021 ASH 2021 Hemophilia

Updated Results of the Alta Study, a Phase 1/2 Study of Giroctocogene Fitelparvovec (PF-07055480/SB-525) Gene Therapy in Adults With Severe Hemophilia A

View Presentation
Oral Presentation
Lisa Young, Leona Markson, José Alvir, Yong Chen, Tom Burke, Ian Winburn February 2, 2022 EAHAD 2022 Hemophilia

Association Between Annual Bleeding Events and Health-Related Quality of Life in Adults With Haemophilia A Prescribed Prophylaxis

View Presentation
Oral Presentation
Sangeeta Raje, Anna Plotka, Isabelle Huyghe, John Teeter February 2, 2022 EAHAD 2022 Hemophilia

Bioequivalence (BE) of Marstacimab Prefilled Pen (PFP) Device and Prefilled Syringe (PFS) Device Following Subcutaneous (SC) Administration in Healthy Adult Males

View Presentation
Oral Presentation
Jeremy Rupon, Brinda K Tammara, Justin Smith, Delphine Agathon, Florence Ganne, Patrick F Fogarty, Frank Plonski February 2, 2022 EAHAD 2022 Hemophilia

Clearance of Giroctocogene Fitelparvovec Vector DNA in Adults With Severe Haemophilia A

View Presentation
Oral Presentation
Nirmalkumar Choraria, Savita Rangarajan, M Joseph John, Shashikant Apte, Pritam Gupta, Seema Pai, Rohit Chand, Shyam Parvatini, GSH Ramakanth, Jeremy Rupon, Hitesh Bhaskarrao Muley, Damien Simoneau February 2, 2022 EAHAD 2022 Hemophilia

Moroctocog Alfa (AF-CC) Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients With Moderate or Severe Hemophilia A in India

View Presentation